Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Loss of Bcl-2 expression in colon cancer: A prognostic factor for recurrence in stage II colon cancer
Surgical Oncology, 11/05/09
Poincloux L et al. – The loss of Bcl–2 expression appears to be correlated with increase in number of relapses in the stage II colon cancers and could be a potential useful additional histo–prognostic marker in therapy decision making. Bcl–2 immunodetection seems to be associated with slower local tumour growth.
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
American Journal of Clinical Nutrition, 10/29/09
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


